Cadrenal Therapeutics, Inc. (CVKD) vs OSR Health, Inc. (OSRH)

Cadrenal Therapeutics, Inc. and OSR Health, Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. and OSR Health, Inc. are of similar size ($4.3M and $4.1M). Cadrenal Therapeutics, Inc. has the higher net margin (0.00% vs −1,093.4%) and the lower return on invested capital (−427.5% vs −8.19%). Across the 14 metrics below, OSR Health, Inc. leads on 9 and Cadrenal Therapeutics, Inc. on 5.

Valuation

Metric CVKD OSRH Biotechnology median
P/E n/m n/m 7.88
P/S n/m 4.00 11.47
P/B 0.82 0.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 6.17 10.73
Earnings yield (426.09%) (168.18%) (28.84%)
Free cash flow yield (303.35%) (105.52%) (23.03%)

Profitability

Metric CVKD OSRH Biotechnology median
Gross margin 0.00% 35.29% 65.16%
Operating margin 0.00% (933.72%) 0.00%
Net margin 0.00% (1,093.41%) 0.00%
Free cash flow margin 0.00% (398.26%) 0.00%
Return on equity (275.16%) (14.98%) (57.72%)
Return on assets (199.59%) (11.24%) (49.22%)
Return on invested capital (427.54%) (8.19%) 0.00%

Growth

Metric CVKD OSRH Biotechnology median
Revenue growth (TTM) — (50.24%) 5.64%
EPS growth (last fiscal year) 23.94% 71.07% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CVKD OSRH Biotechnology median
Debt to equity 0.00 0.04 0.00
Current ratio 3.73 0.18 4.73
Net debt to EBITDA 0.30 (0.29) 0.96

Dividend

Metric CVKD OSRH Biotechnology median
Dividend yield — — 2.10%
Payout ratio — — 0.00

Size

Metric CVKD OSRH Biotechnology median
Market cap 4.29m 4.09m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack